Medicalsystem Biotechnology Co., Ltd (SZSE: 300439)
Health Care · Biotechnology · CN
CN¥10.31
+0.59% today · +0.5% 1Y
Medicalsystem Biotechnology Co., Ltd (SZSE: 300439) operates in the Biotechnology industry within the Health Care sector. The company is valued at $591.56M and employs 1,936 people.
Over the last twelve months the share price has gained 0.5%, trading between 7.83 and 11.11.
Tweenvest scores Medicalsystem Biotechnology Co., Ltd across four factors: quality 70/100, value 25/100, growth 0/100, dividend 28/100. Its strongest factor is quality.
300439 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $591.56M
- Revenue (TTM)
- $240.10M
- P/E
- 59.63
- EPS
- 0.17
- Dividend yield
- 0.32%
- Beta (5Y)
- 0.31
- 52-week high
- CN¥11.11
- 52-week low
- CN¥7.83
- Avg volume (3M)
- —
- Shares outstanding
- 384.32M
- Employees
- 1,936
- Next earnings
- —
About Medicalsystem Biotechnology Co., Ltd
Medicalsystem Biotechnology Co., Ltd. is a Chinese company focused on delivering clinical diagnostic solutions. Their comprehensive product line includes a full array of reagents and instruments designed for COVID-19 detection, such as PCR, antibody, and antigen test kits, alongside nucleic acid reagents. Beyond infectious disease diagnostics, the company also supplies advanced medical equipment like automated biochemistry analyzers (complete with their corresponding bio-reagents), hematology analyzers, urine analyzers, and glycated hemoglobin analyzers. Additionally, their offerings extend to Point-of-Care Testing (POCT) devices and cutting-edge chemiluminescence immunoassay analyzers. In addition to its diagnostic product offerings, Medicalsystem also provides healthcare services. Initially established in 2003 as Ningbo Medicalsystem Biotechnology Co., Ltd., the company officially adopted its current name, Medicalsystem Biotechnology Co., Ltd., in January 2017. Its corporate headquarters are situated in Ningbo, China.
- ISIN
- CNE100001Z25
- Founded
- 2003
- Listed since
- Apr 22, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Beijing Science Sun Pharmaceutical Co., Ltd.SZSE: 300485 | $616.28M | CN¥8.57 | -0.92% |
| Shattuck Labs, Inc.NasdaqGS: STTK | $599.17M | $6.09 | +2.01% |
| Berry Genomics Co.,LtdSZSE: 000710 | $596.41M | CN¥11.30 | +3.96% |
| Silence Therapeutics plcNasdaqGM: SLN | $593.66M | $9.65 | -2.13% |
| Blau Farmacêutica S.A.BOVESPA: BLAU3 | $584.71M | R$12.61 | +16.54% |
| Landfar Bio-medicine Co., LtdSZSE: 000504 | $580.91M | CN¥11.79 | -5.07% |
| Guangdong Hybribio Biotech Co.,Ltd.SZSE: 300639 | $575.67M | CN¥6.14 | -2.07% |
| Pharmicell Co., Ltd.KOSE: A005690 | $573.98M | ₩12,860.00 | +3.71% |
Figures last refreshed Oct 11, 2026.